GSK PLC Sponsored ADR (GSK)
(Delayed Data from NYSE)
$41.21 USD
-0.33 (-0.79%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $41.20 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 34% (85 out of 248)Zacks Sector Rank
Top 44% (7 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.00 | 2.10 | 9.99 |
Current Quarter Estimate | 0.99 | 37.64 | 57.00 |
Year Ago Quarter Estimate | 0.97 | 11.39 | 52.54 |
Next Quarter Estimate | 1.28 | 34.85 | 61.00 |
Next Year Estimate | 4.53 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 6.22 | 15.30 | 15.67 |
Next Year | 10.49 | 8.80 | 9.31 |
Last 5 Years | 0.10 | 1.00 | 8.10 |
Next 5 Years | 8.10 | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 10.20 | 15.53 |
Price/Book (MRQ) | 5.09 | 2.15 |
Price/Cash Flow (MRFY) | 7.95 | 17.00 |
Dividend Yield | 3.58% | 0.00% |
Net Profit Margin (TTM) | 14.62% | -164.45% |
Return on Equity (TTM) | 51.54% | -59.04% |
Debt to Equity (MRQ) | 1.15 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.